0.5 mg/kg IM, PO q24h
Dexamethasone sodium phosphate —0.1–0.3 mg/kg IM, SC, IV q24h for 3 days
Ceftazidime: 22 mg/kg IM q72h
Ceftiofur crytasalline free acid: 30 mg/kg SC q5d
Amikacin: 5 mg/kg IM q48h
Enrofloxacin: 5–10 mg/kg IM, PO q24–48h
Oxytetracycline: 5–10 mg/kg IM q24h; 10 mg/kg IM q5d for long‐acting formulation
Ophthalmic Therapy
Ophthalmic antibiotics applied 3–4 times daily
Ophthalmic anti‐inflammatory applied 3–4 times daily
PRECAUTIONS/INTERACTIONS
Vitamin A must be administered only in cases with clear indication of hypovitaminosis A, otherwise there is a risk of causing hypervitaminosis A.
PATIENT MONITORING
Weekly to every two‐week re‐evaluations are recommended to determine response to therapy.
EXPECTED COURSE AND PROGNOSIS
Course and prognosis will vary according to the etiology.
Prognosis for viral infections is grave as these animals typically become progressively worse over time.
For other etiologies prognosis is good to excellent.
COMMENTS
Figure 2—see web image supplementary content for Section II (Chelonians).
ZOONOTIC POTENTIAL
Low for the most common etiologies.
SYNONYMS
N/A
ABBREVIATIONS
IM = intramuscular
IV = intravenous
PCR = polymerase chain reaction
PO = per os
SC = subcutaneous
Suggested Reading
1 Di Ianni F, Dodi PL, Cabassi CS, et al. Conjunctival flora of clinically normal and diseased turtles and tortoises. BMC Vet Res 2015;11:91.
2 Lawton, MPC. Reptilian Ophthalmology. In: Mader DR, ed. Reptile Medicine and Surgery. 2nd ed. St. Louis, MO: Elsevier Saunders; 2006:323–342.
Author Javier G. Nevarez, DVM, PhD, DACZM, DECZM (Herpetology)
Cryptosporidium
DEFINITION/OVERVIEW
Cryptosporidia are apicomplexan parasites typified by possessing an apical complex, and with four naked sporozites within each oocyte. Cryptosporidia can be distinguished from other coccidian parasites by the location that they occupy within the host cell membrane, their capacity for autoinfection, and their resistance to anti‐parasitic medication. Possessing a durable oocyst wall consisting of a double layer of a protein–lipid–carbohydrate matrix, cryptosporidia are highly resistant to environmental degradation and chemical disinfection. Historically, oocyst morphology has been used for species identification, but this is considered unreliable and species assignment is now determined by molecular characteristics. Cryptosporidia are ubiquitous in the environment and are globally distributed.
ETIOLOGY/PATHOPHYSIOLOGY
Cryptosporidium pestis has been recovered from captive tortoises, with an additional species in chelonians, C. ducismarci, yet to be ratified.
C. ducismarci has been isolated from intestinal lesions in tortoises and additionally from asymptomatic ball pythons and chameleons.
Cryptosporidium oocysts from chelonians can cause severe infections in snakes when experimentally transferred.
Transmission is direct, with reptiles becoming infected after ingesting oocysts that have been shed in feces.
Autoinfection may also occur with some oocysts releasing their sporozoites within the host’s body.
No pre‐patent period has been determined.
SIGNALMENT/HISTORY
Infected animals usually have a history of chronic wasting accompanied by diarrhea and inappetence.
CLINICAL PRESENTATION
Subclinical (carrier state): animals may appear healthy and are able to shed oocysts intermittently for years.
Enteritis: a chronic debilitating enteritis without gastric involvement that may be accompanied by concurrent disease.
RISK FACTORS
The greatest risk factor for developing infection is poor quarantine of new animals entering a collection.
Husbandry
N/A
Others
N/A
DIFFERENTIAL DIAGNOSIS
